Form 4 for VYGR Voyager Therapeutics, Inc.
Accepted 2023-07-10 00:00:00 ET · period of report 2023-07-06 · accession 0001104659-23-079686 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-10 | 2023-07-06 | VYGR | Carter Todd Alfred | CSO | S - Sale | $10.80 | -5,500 | 59.9K | -8% | -$59.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-06 | S | D | 5,500 | $10.80 | 59,860 | D | — | — | (F1) The reported sale of 5,500 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023. |